March 17, 2025

President Trump signed the Full-Year Continuing Appropriations and Extensions Act of 2025 March 15, keeping the government open through Sept. 30, the end of the federal fiscal year (FY). The act stopped a scheduled government shutdown and funds non-defense federal agencies and programs at approximately FY 2024 levels.

The law extends statutory language preventing the administration from imposing a 15% cap on Facilities and Administrative (F&A) cost reimbursement. The American College of Radiology® (ACR®) previously reported the intent of the National Institutes of Health (NIH) to cut research F&A reimbursement; however, a temporary restraining order was put in place to halt implementation of the cuts as there are multiple lawsuits pending in the courts..

ACR joined a coalition letter urging prioritization of robust NIH funding in lawmakers’ federal FY 2025 appropriations bill and preservation of existing protections against cuts to reimbursements for NIH grantee F&A costs. NIH funding encompasses support for radiology research, which includes a wide range of diagnostics, treatments and therapeutics that benefit patients and their families.

Congress nonetheless failed to include an increase to the Medicare Physician Fee Schedule (MPFS) conversion factor in this legislation. Therefore, the current MPFS conversion factor is approximately 2.8% below the 2024 conversion factor.

ACR will continue to work with our colleagues across the healthcare profession to include long-term Medicare payment reform in the government funding package expected later this year.

For more information or if you have questions, contact Katie Grady, ACR Government Affairs Director.

Related ACR News

  • CMS Releases 2026 Medicare Physician Fee Schedule Final Rule

    CMS released the 2026 MPFS final rule Oct. 31. ACR prepared an initial summary about impact on imaging.

    Read more
  • Massachusetts Legislature Updates Prior Authorization Bill

    Massachusetts HB 4616 aims to streamline prior authorization, boost transparency, and study its impact on care access and costs.

    Read more
  • ACR Responds to RFI on AI Regulatory Reform

    ACR urged the White House to enhance AI oversight and payment policies to support safe, effective, and reimbursable clinical AI use.

    Read more